Literature DB >> 31642575

Revisions of Medicare reimbursement policy for ambulatory blood pressure monitoring and the role of qualitative analysis.

Garrett I Ash1,2.   

Abstract

Entities:  

Keywords:  ambulatory blood pressure/home blood pressure monitor; clinical management of high blood pressure (HBP); cost/economics

Mesh：

Year:  2019        PMID： 31642575      PMCID： PMC8030408          DOI： 10.1111/jch.13715

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  17 in total

1.  Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement.

Authors:  Albert L Siu
Journal:  Ann Intern Med       Date:  2015-10-13       Impact factor: 25.391

Review 2.  Case and grounded theory as qualitative research methods.

Authors:  Cynthia S Jacelon; Katharine K O'Dell
Journal:  Urol Nurs       Date:  2005-02

3.  Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups.

Authors:  Allison Tong; Peter Sainsbury; Jonathan Craig
Journal:  Int J Qual Health Care       Date:  2007-09-14       Impact factor: 2.038

4.  History and Justification of a National Blood Pressure Measurement Validated Device Listing.

Authors:  Jordana B Cohen; Raj S Padwal; Michael Gutkin; Beverly B Green; Michael J Bloch; F Wilford Germino; Domenic A Sica; Anthony J Viera; Benjamin M Bluml; William B White; Sandra J Taler; Steven Yarows; Daichi Shimbo; Raymond R Townsend
Journal:  Hypertension       Date:  2019-02       Impact factor: 10.190

Review 5.  Non-dipping status in arterial hypertension: an overview.

Authors:  Maria Sarigianni; Konstantinos Dimitrakopoulos; Apostolos Tsapas
Journal:  Curr Vasc Pharmacol       Date:  2014-05       Impact factor: 2.719

Review 6.  Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the U.S. Preventive Services Task Force.

Authors:  Margaret A Piper; Corinne V Evans; Brittany U Burda; Karen L Margolis; Elizabeth O'Connor; Evelyn P Whitlock
Journal:  Ann Intern Med       Date:  2015-02-03       Impact factor: 25.391

Review 7.  Cost-effectiveness of secondary screening modalities for hypertension.

Authors:  Y Claire Wang; Alisa M Koval; Miyabi Nakamura; Jonathan D Newman; Joseph E Schwartz; Patricia W Stone
Journal:  Blood Press Monit       Date:  2013-02       Impact factor: 1.444

8.  European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring.

Authors:  Gianfranco Parati; George Stergiou; Eoin O'Brien; Roland Asmar; Lawrence Beilin; Grzegorz Bilo; Denis Clement; Alejandro de la Sierra; Peter de Leeuw; Eamon Dolan; Robert Fagard; John Graves; Geoffrey A Head; Yutaka Imai; Kazuomi Kario; Empar Lurbe; Jean-Michel Mallion; Giuseppe Mancia; Thomas Mengden; Martin Myers; Gbenga Ogedegbe; Takayoshi Ohkubo; Stefano Omboni; Paolo Palatini; Josep Redon; Luis M Ruilope; Andrew Shennan; Jan A Staessen; Gert vanMontfrans; Paolo Verdecchia; Bernard Waeber; Jiguang Wang; Alberto Zanchetti; Yuqing Zhang
Journal:  J Hypertens       Date:  2014-07       Impact factor: 4.844

9.  Revisions of Medicare reimbursement policy for ambulatory blood pressure monitoring and the role of qualitative analysis.

Authors:  Garrett I Ash
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-10-23       Impact factor: 3.738

10.  Ambulatory blood pressure monitoring and diabetes complications: Targeting morning blood pressure surge and nocturnal dipping.

Authors:  Mohammad Taghi Najafi; Pegah Khaloo; Hamid Alemi; Asma Jaafarinia; Michael J Blaha; Mohammadhassan Mirbolouk; Mohammad Ali Mansournia; Mohsen Afarideh; Sadaf Esteghamati; Manouchehr Nakhjavani; Alireza Esteghamati
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817
View more
  1 in total

1.  Revisions of Medicare reimbursement policy for ambulatory blood pressure monitoring and the role of qualitative analysis.

Authors:  Garrett I Ash
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-10-23       Impact factor: 3.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.